Table 2 Changes in secondary outcomes from baseline to week 8 on each diet, and differences in changes in outcomes from baseline to week 8 between diets

From: Ultraprocessed or minimally processed diets following healthy dietary guidelines on weight and cardiometabolic health: a randomized, crossover trial

ITT N = 50

MPF diet

UPF diet

MPF diet − UPF diet

Mean

Lower 95% CI

Upper 95% CI

Mean

Lower 95% CI

Upper 95% CI

Mean

s.e.

Lower 95% CI

Upper 95% CI

P value

Weight (kg)

−1.84

−2.68

−1.00

−0.88

−1.72

−0.05

−0.96

0.40

−1.76

−0.17

0.019

BMI (kg m−2)

−0.67

−0.98

−0.37

−0.33

−0.63

−0.03

−0.34

0.14

−0.63

−0.05

0.021

Waist circumference (cm)

−1.70

−3.52

0.12

−0.18

−1.94

1.57

−1.51

1.03

−3.59

0.56

0.148

Fat mass (kg)

−1.59

−2.32

−0.85

−0.61

−1.34

0.12

−0.98

0.32

−1.62

−0.33

0.004

Body fat percentage (%)

−1.08

−1.66

−0.51

−0.32

−0.89

0.24

−0.76

0.28

−1.33

−0.19

0.010

Visceral fat rating

−0.57

−0.81

−0.32

−0.16

−0.40

0.08

−0.41

0.15

−0.70

−0.11

0.008

Fat-free mass (kg)

−0.30

−0.78

0.19

−0.30

−0.77

0.18

0.00

0.28

−0.57

0.57

0.993

Muscle mass (kg)

−0.29

−0.75

0.17

−0.28

−0.73

0.17

−0.01

0.27

−0.55

0.54

0.980

Bone mass (kg)

−0.01

−0.03

0.02

−0.02

−0.04

0.01

0.01

0.02

−0.02

0.04

0.569

Total body water mass (kg)

−0.65

−0.96

−0.33

−0.14

−0.45

0.17

−0.51

0.15

−0.81

−0.20

0.002

Total body water percentage (%)

0.21

−0.15

0.56

0.30

−0.05

0.65

−0.10

0.16

−0.42

0.23

0.563

SBP (mm Hg)

−5.75

−10.13

−1.36

−2.67

−7.01

1.67

−3.08

2.44

−7.99

1.84

0.214

DBP (mm Hg)

−3.52

−6.02

−1.02

−1.88

−4.35

0.60

−1.64

1.46

−4.59

1.31

0.268

HR (beats per minute)

−3.57

−7.56

0.42

−4.35

−8.28

−0.42

0.78

2.36

−3.97

5.53

0.743

Bilirubin (μmol l−1)

0.15

−1.05

1.36

0.70

−0.47

1.87

−0.54

0.49

−1.53

0.45

0.274

Alkaline phosphatase (IU l−1)

0.33

−3.17

3.83

−0.51

−3.78

2.77

0.83

2.08

−3.37

5.04

0.690

Alanine transaminase (IU l−1)

1.99

−3.34

7.32

−0.52

−5.53

4.50

2.51

2.63

−2.83

7.84

0.347

Albumin (g l−1)

−0.18

−1.01

0.64

−0.09

−0.89

0.70

−0.09

0.48

−1.06

0.88

0.852

HbA1c (%)

−0.08

−0.15

−0.01

−0.03

−0.09

0.04

−0.06

0.04

−0.14

0.02

0.165

Fasting glucose (mmol l−1)

−0.13

−0.27

0.00

−0.19

−0.32

−0.06

0.05

0.08

−0.10

0.21

0.488

Total cholesterol (mmol l−1)

−0.31

−0.51

−0.10

−0.44

−0.63

−0.24

0.13

0.12

−0.11

0.37

0.283

Total-cholesterol-to-HDL ratio

−0.04

−0.21

0.13

−0.13

−0.30

0.03

0.09

0.10

−0.11

0.29

0.368

HDL-C (mmol l−1)

−0.11

−0.19

−0.03

−0.08

−0.16

−0.01

−0.03

0.05

−0.12

0.07

0.575

LDL-C (mmol l−1)

−0.13

−0.30

0.03

−0.38

−0.54

−0.22

0.25

0.10

0.05

0.45

0.016

Non-HDL-C (mmol l−1)

−0.22

−0.41

−0.03

−0.36

−0.54

−0.17

0.14

0.11

−0.09

0.36

0.234

Triglycerides (mmol l−1)

−0.18

−0.32

−0.04

0.07

−0.06

0.20

−0.25

0.08

−0.42

−0.09

0.004

C-reactive protein (mg l−1)

−0.80

−1.90

0.31

−0.38

−1.44

0.69

−0.42

0.64

−1.72

0.88

0.519

PFS food available

−0.41

−0.84

0.03

−0.12

−0.56

0.31

−0.28

0.18

−0.65

0.08

0.125

PFS food present

−0.67

−1.15

−0.19

−0.38

−0.86

0.10

−0.29

0.18

−0.66

0.08

0.122

PFS food tasted

−0.40

−0.79

−0.01

−0.21

−0.61

0.18

−0.19

0.17

−0.53

0.15

0.275

PFS total

−0.50

−0.88

−0.11

−0.24

−0.63

0.15

−0.25

0.14

−0.55

0.04

0.089

CoEQ craving control

23.81

12.52

35.09

12.13

0.76

23.49

11.68

4.74

2.07

21.28

0.019

CoEQ craving for sweet

−9.67

−16.54

−2.81

−2.70

−9.61

4.21

−6.97

3.52

−14.10

0.16

0.055

CoEQ craving for savory

−13.39

−21.57

−5.22

−2.94

−11.16

5.28

−10.46

4.12

−18.80

−2.12

0.015

CoEQ positive mood

−1.23

−9.10

6.64

2.60

−5.33

10.52

−3.83

3.13

−10.18

2.52

0.229

CoEQ control over craved nominated food

−28.44

−45.41

−11.47

−14.67

−31.76

2.41

−13.77

6.35

−26.66

−0.88

0.037

  1. Estimated marginal means and 95% CIs computed from mixed-effects models adjusted for randomization arm and nightshift status, with an interaction term for diet and randomization arm and a random effect for participant.